Cynosure (CYNO) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	13.35M
Depreciation and amortization	15.54M
Stock-based compensation expense
Gain on investments
Loss on disposal of fixed assets	252K
Deferred income taxes	3.08M
Accretion of discounts on marketable securities	1.91M
Accounts receivable	1.37M
Inventories	-8.91M
Net book value of demonstration inventory sold	525K
Prepaid expenses and other current assets	-5.04M
Accounts payable	-7.5M
Due to related party
Tax benefit from stock option exercises
Accrued expenses	3.9M
Deferred revenue	-3.39M
Other noncurrent liability
Net cash provided by operating activities
Purchases of property and equipment	-10.55M
Proceeds from the sales and maturities of marketable securities	45.98M
Purchases of marketable securities	-56.99M
Acquisitions
Decrease (increase) in other noncurrent assets	-20K
Net cash used in investing activities
Excess tax benefit on options exercised	3.26M
Repurchases of common stock
Proceeds from stock option exercises	22.8M
Payments on capital lease obligation	-1.75M
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents	-184K
Net decrease in cash and cash equivalents	22.41M
Cash and cash equivalents, beginning of the period	108.59M
Cash and cash equivalents, end of the period	131M
Cash paid for interest	14K
Cash paid for income taxes	7.15M
Transfer of demonstration equipment from inventory to fixed assets	5.08M
Net unrealized gain on marketable securities, net of $18 and $11 deferred income tax provision

Entities mentioned with CYNO

View All Entities